Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
242
-
Total 13F shares, excl. options
-
67.5M
-
Shares change
-
+3.64M
-
Total reported value, excl. options
-
$2.01B
-
Value change
-
+$104M
-
Put/Call ratio
-
0.06
-
Number of buys
-
131
-
Number of sells
-
-100
-
Price
-
$29.72
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q3 2017
275 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q3 2017.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 242 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.5M shares
of 115M outstanding shares and own 58.6% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.64M shares), WELLINGTON MANAGEMENT GROUP LLP (6.78M shares), VANGUARD GROUP INC (5.86M shares), JANUS HENDERSON GROUP PLC (3.18M shares), STATE STREET CORP (2.44M shares), Bank of New York Mellon Corp (2.37M shares), Standard Life Aberdeen plc (2.12M shares), DIMENSIONAL FUND ADVISORS LP (1.84M shares), Van Berkom & Associates Inc. (1.84M shares), and GW&K Investment Management, LLC (1.44M shares).
This table shows the top 242 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.